Tenet Healthcare Corporation (THC)
NYSE: THC · Real-Time Price · USD
210.00
-2.14 (-1.01%)
Dec 5, 2025, 4:00 PM EST - Market closed
Tenet Healthcare Stock Forecast
Stock Price Forecast
According to 18 professional analysts, the 12-month price target for Tenet Healthcare stock ranges from a low of $154 to a high of $260. The average analyst price target of $222 forecasts a 5.71% increase in the stock price over the next year.
Price Target: $222.00 (+5.71%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Tenet Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 6 | 6 | 6 |
| Buy | 10 | 10 | 10 | 10 | 10 | 10 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 18 | 19 | 19 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $238 → $257 | Strong Buy | Maintains | $238 → $257 | +22.38% | Dec 2, 2025 |
| Barclays | Barclays | Buy Maintains $229 → $240 | Buy | Maintains | $229 → $240 | +14.29% | Nov 21, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $200 → $230 | Buy | Maintains | $200 → $230 | +9.52% | Nov 13, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $238 → $252 | Buy | Maintains | $238 → $252 | +20.00% | Nov 13, 2025 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $225 → $240 | Strong Buy | Reiterates | $225 → $240 | +14.29% | Nov 3, 2025 |
Financial Forecast
Revenue This Year
21.49B
from 20.67B
Increased by 3.98%
Revenue Next Year
22.43B
from 21.49B
Increased by 4.39%
EPS This Year
16.27
from 32.70
Decreased by -50.26%
EPS Next Year
16.61
from 16.27
Increased by 2.11%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 22.6B | 23.7B | ||||
| Avg | 21.5B | 22.4B | ||||
| Low | 20.8B | 21.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 9.2% | 10.2% | ||||
| Avg | 4.0% | 4.4% | ||||
| Low | 0.5% | -0.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 17.15 | 18.69 | ||||
| Avg | 16.27 | 16.61 | ||||
| Low | 15.45 | 13.92 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -47.6% | 14.9% | ||||
| Avg | -50.3% | 2.1% | ||||
| Low | -52.7% | -14.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.